Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasimogen activator
Lakshminarayanan, S.; Vázquez-Abad, D.; Maestrello, S.J.; Waterman, J.R.
Clinical and Experimental Rheumatology 17(2): 260
1999
ISSN/ISBN: 0392-856X PMID: 10342058 Document Number: 511051
Document emailed within 1 workday
Related Documents
Adair, J.R.; Theobald, D.E. 1978: Raynaud's Phenomenon: treatment of a severe case with biofeedback Journal of the Indiana State Medical Association 71(10): 990-993Neuhauser, B.; Perkmann, R.; Klingler, P.J.; Giacomuzzi, S.; Kofler, A.; Fraedrich, G. 2001: Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon American Surgeon 67(11): 1096-1097
Cuenca, R.; Fernández-Cortijo, J.; Lima, J.; Fonollosa, V.; Simeón, C.P.; Pico, M.; Soriano, B.; Vilardell, M. 1990: Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma Medicina Clinica 95(20): 761-763
Da Costa, J.; Gomes, J.A.; Espirito Santo, J.; Queirós, M. 1987: Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study Journal of Rheumatology 14(4): 858-859
Pratesi, F.; Corsi, C.; Deidda, C.; Nuti, A. 1976: Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon Schweizerische Rundschau für Medizin Praxis 65(44): 1368-1370
Grossi, G.; Mariotti, A.; Di Donato, L.; Amerio, P.; Tulli, A.; Romani, G.L.; Merla, A. 2010: Functional infrared imaging of paroxysmal ischemic events in patients with Raynaud's phenomenon International Journal of Immunopathology and Pharmacology 23(2): 627-632
Kahan, A.; Weber, S.; Amor, B.; Menkes, C.J.; Hodara, M.; Degeorges, M. 1985: Nifedipine and Raynaud's phenomenon associated with connective tissue diseases International Angiology: a Journal of the International Union of Angiology 4(2): 221-223
Denton, C.P.; Howell, K.; Stratton, R.J.; Black, C.M. 2000: Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study Clinical and Experimental Rheumatology 18(4): 499-502
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Nakazato, K.; Sakurai, T.; Kubota, K.; Kurabayashi, H.; Tamura, J.; Shirakura, T. 1988: Whole-blood and plasma viscosity in two cases of mixed connective tissue disease with Raynaud's phenomenon and cold agglutinemia Rinsho Byori. Japanese Journal of Clinical Pathology 36(10): 1201-1204
Bart, P.A.; Waeber, B. 2006: Understanding Raynaud's phenomenon: towards a better treatment Revue Medicale Suisse 2(48): 93-96
Thulesius, O. 1979: Psychiatric treatment of Raynaud's phenomenon Lakartidningen 76(47): 4234
Delgado Daza, R.; Moga Donadeu, L.; Mañosa Bonamich, J.; Muncunill Gil, J.; Vidal Conde, V. 1991: Thoracic sympathectomy in the surgical treatment of Raynaud's phenomenon Angiologia 43(5): 180-182
Di Biase, A. 2013: Mesoglycan treatment in Raynaud phenomenon: a case series Minerva Cardioangiologica 61(3): 323-331
Buryĭ, V.T.; Buryĭ, V.V. 2008: The treatment of neurospastic vascular diseases in Raynaud phenomenon Klinichna Khirurhiia 6: 36-39
Kahan, A.; Weber, S.; Amor, B.; Guerin, F.; Degeorges, M. 1983: Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon New England Journal of Medicine 308(18): 1102-1103
Maricq, H.R.; Harper, F.E.; Khan, M.M.; Tan, E.M.; LeRoy, E.C. 1983: Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease Clinical and Experimental Rheumatology 1(3): 195-205
Dowd, P.M.; Martin, M.F.; Cooke, E.D.; Bowcock, S.A.; Jones, R.; Dieppe, P.A.; Kirby, J.D. 1982: Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2) British Journal of Dermatology 106(1): 81-89
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Saudi Medical Journal 23(1): 13-19
Al-Buhairi, A.R.; Jan, M.M. 2002: Recombinant tissue plasminogen activator for acute ischemic stroke Neurosciences 7(1): 7-13